SCHEMBL13637157

SCHEMBL13637157

Nc1ccc(OCCCOc2ccc(OCC(=O)O)cc2)c(N2Cc3ccccc3C2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 7/20 0.47
PPARG P37231 6/20 0.47
PPARA Q07869 3/20 0.47
PTGDR2 Q9Y5Y4 1/20 0.44
MAPT P10636 4/20 0.41
LMNA P02545 2/20 0.41
ALOX15 P16050 1/20 0.40
CYP1A2 P05177 2/20 0.39
CYP2C9 P11712 1/20 0.39
NFKB1 P19838 1/20 0.39
BLM P54132 1/20 0.39
TSHR P16473 2/20 0.39
HSD17B10 Q99714 2/20 0.39
HPGD P15428 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MCL1 Q07820 2/20 0.39
FFAR1 O14842 2/20 0.39
PTPN7 P35236 2/20 0.39
PLA2G4B P0C869 1/20 0.38
MEN1 O00255 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13441826 0.87 ALDH1A1 (0.51) PPARDPPARGPPARAPTGDR2MAPT
SCHEMBL13441808 0.77 PPARD (0.41) PPARDPPARGPPARAPTGDR2MAPT
SCHEMBL13441639 0.77 ALDH1A1 (0.49) PPARDPPARGPPARAMAPTLMNA
SCHEMBL13441807 0.74 PTGDR2 (0.58) PPARDPPARGPPARAPTGDR2CYP2C9
SCHEMBL13441823 0.72 PPARG (0.51) PPARDPPARGPPARAMAPTHPGD
SCHEMBL13637151 0.72 PPARG (0.46) PPARDPPARGPPARAPTGDR2MAPT
SCHEMBL13637153 0.71 PPARD (0.36) PPARDPPARGPPARAPTGDR2MAPT
SCHEMBL13637155 0.69 PTGDR2 (0.61) PPARDPPARGPPARAPTGDR2CYP2C9
SCHEMBL8768551 0.68 ALOX15 (0.80) PPARDPPARGPPARAMAPTALOX15
SCHEMBL655820 0.68 ALOX15 (0.65) PPARDPPARGPTGDR2MAPTALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7622491-B2 Type 2 diabetes, atherosclerosis, cardiovascular disease, Syndrome X; carboxylic acids with dialkyldiether or thioether linking groups e.g. {4-[3-(2-Benzotriazol-2-yl-4-chloro-phenoxy)-propoxy]-phenyl}-acetic acid and {4-[3-(2-benzotriazol-2-yl-4-thiophen-2-yl-phenoxy)-propoxy]-phenyl}-acetic acid METABOLEX INC. (US) 2009-11-24 US disclosed